ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018
MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
Open access · greenAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 74 citations in OpenAlex.
- Synthesis and Development of Novel Small-Molecule MEIS2 Inhibitors That Induce Cell Death in Breast Cancer Cells by Targeting the Homeobox Domain.Pharmaceuticals (Basel, Switzerland) · 2026Article
- DNA framework-based molecular transformer for logic-driven precision diagnostics.Science advances · 2026Article
- Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer.BMC cancer · 2026Article
- Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- MEIS1‑regulated miR‑488‑3p suppresses the malignant progression of laryngeal squamous cell carcinoma by targeting ACVR1C.International journal of molecular medicine · 2025Article
- Bioinformatics mining and experimental validation of prognostic biomarkers in colorectal cancer.Discover oncology · 2025Article
- A comprehensive transcriptome based meta-analysis to unveil the aggression nexus of oral squamous cell carcinoma.Biochemistry and biophysics reports · 2025Article
- HOXB13 in cancer development: molecular mechanisms and clinical implications.Frontiers of medicine · 2025Review
- MEIS1 knockdown upregulates WNT signaling pathway genes in esophageal squamous cell carcinoma.BMC medical genomics · 2025Article
- RLS-associated MEIS transcription factors control distinct processes in human neural stem cells.Scientific reports · 2024Article
- MEIS2 suppresses breast cancer development by downregulating IL10.Cancer reports (Hoboken, N.J.) · 2024Article
- A Comprehensive Analysis of HOXB13 Expression in Hepatocellular Carcinoma.Medicina (Kaunas, Lithuania) · 2024Article
- Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals.Pharmaceutics · 2024Review
- Cleft palate, congenital heart disease, and developmental delay involvingFrontiers in pediatrics · 2024Article
- The impact ofAnimal cells and systems · 2024Article
- Mechanistic insights into cardiac regeneration and protection through MEIS inhibition.Turkish journal of biology = Turk biyoloji dergisi · 2024Article
- CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis.Epigenetics · 2023Article
- Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging.Biomedicines · 2023Review
- Editorial: Hormone resistance in cancer.Frontiers in endocrinology · 2023Article
- Molecular characteristics, clinical significance, and immune landscape of extracellular matrix remodeling-associated genes in colorectal cancer.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 3 institutions in 2 countries.
Raj R Bhanvadia *The Pritzker School of Medicine, The University of Chicago, Chicago, Illinois.
Calvin VanOpstall *The Committee on Cancer Biology, The University of Chicago, Chicago, Illinois.
Hannah BrechkaThe Committee on Cancer Biology, The University of Chicago, Chicago, Illinois.
Nimrod S BarashiDepartment of Surgery, Section of Urology, The University of Chicago, Chicago, Illinois.
Marc GillardDepartment of Surgery, Section of Urology, The University of Chicago, Chicago, Illinois.
Erin M McAuleyThe Committee on Molecular Pathology and Molecular Medicine, The University of Chicago, Chicago, Illinois.
Juan Manuel VasquezThe Post-Baccalaureate Research Education Program (PREP), The University of Chicago, Chicago, Illinois.
Gladell PanerThe Department of Pathology, The University of Chicago, Chicago, Illinois.
Wen-Ching ChanThe Center for Research Informatics, The University of Chicago, Chicago, Illinois.
Jorge AndradeThe Center for Research Informatics, The University of Chicago, Chicago, Illinois.
Angelo M De MarzoThe Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland.
Misop HanThe Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland.
Russell Z SzmulewitzDepartment of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, Illinois.
Donald J Vander GriendThe Committee on Cancer Biology, The University of Chicago, Chicago, Illinois. prostate@uchicago.edu.ORCID 0000-0003-4421-5698
University of Chicago · USJohns Hopkins University · USInternational Baccalaureate · CH
Funding
VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1MTRANSGENIC MODELS FOR PROSTATE CANCER AND AUTOIMMUNITYP50CA058236 · NCI · JOHNS HOPKINS UNIVERSITY · PI DENMEADE, SAMUEL R · 1992 to 2020
$43.9MRe-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2MTargeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancerP50CA180995 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., HUSSAIN, MAHA H · 2015 to 2025
$19.9MMulti-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5MUNIVERSITY OF CHICAGO PREPR25GM066522 · NIGMS · UNIVERSITY OF CHICAGO · PI CARRILLO, ROBERT ARNULFO, RANDALL, GLENN C · 2004 to 2024
$6.7MShort Term Training: Health Professional StudentsT35DK062719 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 2003 to 2017
$2.9MFunction of the Stem Cell Transcription Factor Sox2 in Prostate CancerR01CA178431 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VANDER GRIEND, DONALD JAMES · 2014 to 2018
$1.9MThe Role of Sox2 in prostate epithelium development, regeneration and hyperplasiaF31DK111131 · NIDDK · UNIVERSITY OF CHICAGO · PI MCAULEY, ERIN · 2016 to 2017
$76kNCATS NIH HHS UL1 TR000430NCI NIH HHS P30 CA014599NCI NIH HHS P50 CA058236NCI NIH HHS P50 CA180995NCI NIH HHS R01 CA178431NCI NIH HHS T32 CA009594NIDDK NIH HHS F31 DK111131NIDDK NIH HHS T35 DK062719NIGMS NIH HHS R25 GM066522
Abstract
PubMed holds no abstract for this paper.
Indexed as
Disease ProgressionAdultAgedGene Expression Regulation, NeoplasticHomeodomain ProteinsHumansMaleMiddle AgedMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm MetastasisNeoplasm ProteinsProstateProstatic NeoplasmsProtein BindingSignal TransductionTissue Array AnalysisHomeodomain ProteinsHOXB13 protein, humanMEIS1 protein, humanMEIS2 protein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsTranscription Factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.